Pioneering Neurotech & AI Investments
Our mission is to catalyze the commercial development of Neuro-AI to transform lives and revolutionize industries
Breaking Ground in New Frontiers
Investing in Neurotech & the Future of Computation
From silicon to synapses, we believe the brain is the next major platform across life science and technology, backing visionary founders at the intersection of brain science and artificial intelligence. Our carefully curated portfolio represents breakthrough technologies in neural engineering, brain-computer interfaces, and deep AI applications.
Human-Computer Interfaces
Accelerated Computing
Human Performance & Longevity
Drug Development
Therapeutic Neurostimulation
Brain-Mapping & Medical Imaging
Not Just Investors- Neurotech Pioneers
Led by Dr. Ariane Tom, the firm leverages the expertise of world-class engineers, investors, and policy leaders who have dedicated their careers to emerging technology for neuroscience innovation.
Kaleida Capital in the News
-
![Raise Global Summit]()
Kaleida selected as top 100 out of 700+ managers to attend RAISE Global Summit 2023, GP Panelist: "Frontiers of Deeptech"
-
![]()
Kaleida to speak at NANS Annual Meeting in 2024: "Funding Outlook for Neuromodulation Startups "
-
![]()
Kaleida awarded $100k grant funding as one of 36 emerging fund managers for inaugural Recast Accelerate Program
-
![]()
Kaleida releases publication with the Bakar Institute for Public Policy: "7 Steps for Igniting Brain Capital Industrial Strategy"
-
![]()
Kaleida invited to present at the Caltech Entrepreneur's Forum on Brain Computer Interfaces
